Cargando…
Mesenchymal stem cells from different sources show distinct therapeutic effects in hyperoxia‐induced bronchopulmonary dysplasia in rats
Mesenchymal stem cells (MSCs) have been shown as an effective medicinal means to treat bronchopulmonary dysplasia (BPD). The widely used MSCs were from Wharton's jelly of umbilical cord (UC‐MSCs) and bone marrow (BM‐MSCs). Amniotic fluid MSCs (AF‐MSCs) may be produced before an individual is bo...
Autores principales: | Xie, Yingjun, Chen, Fei, Jia, Lei, Chen, Rui, Zhang, Victor Wei, Zhong, Xinqi, Wang, Ding |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419191/ https://www.ncbi.nlm.nih.gov/pubmed/34322990 http://dx.doi.org/10.1111/jcmm.16817 |
Ejemplares similares
-
Hyperoxia-induced bronchopulmonary dysplasia: better models for better therapies
por: Giusto, Kiersten, et al.
Publicado: (2021) -
Effects of Hyperoxia on Mitochondrial Homeostasis: Are Mitochondria the Hub for Bronchopulmonary Dysplasia?
por: Xuefei, Yu, et al.
Publicado: (2021) -
Deficiency of endothelial FGFR1 alleviates hyperoxia-induced bronchopulmonary dysplasia in neonatal mice
por: Long, Yanrong, et al.
Publicado: (2022) -
Antioxidative effects of caffeine in a hyperoxia-based rat model of bronchopulmonary dysplasia
por: Endesfelder, Stefanie, et al.
Publicado: (2019) -
Cell Division Cycle 2 Protects Neonatal Rats Against Hyperoxia-Induced Bronchopulmonary Dysplasia
por: Li, Zhongying, et al.
Publicado: (2020)